Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 17 of 17 for “"UGT2B7"”.

  1. Studies investigating the impact of select genotypes on the pharmacological effect of fenofibrate

    … variability. We identified a genetic variation, UGT2B7 A-327G, harbored in a key metabolizing gene of fenofibrate. It was the source of a 17% differences in the percent-change of triglycerides, post-fenofibrate treatment, between UGT2B7 A-327G genotype groups. We hypothesized that this lipid …

    umn Repository record for Studies investigating the impact of select genotypes on the pharmacological effect of fenofibrate (opens in a new tab)

  2. UDP-Glucuronosyltransferase (UGT) Genetic Variants and their Potential Role in Carcinogenesis

    … UGT1A9, UGT1A10, and UGT2B7, have been shown to play an important role in the phase II metabolism of carcinogenic metabolites of BaP. Because UGT1A9 and UGT2B7 are well-expressed in digestive tract tissues including liver and colon, it is possible that genetic …

    usf Repository record for UDP-Glucuronosyltransferase (UGT) Genetic Variants and their Potential Role in Carcinogenesis (opens in a new tab)

  3. Therapeutic and Substance Abuse Biomarkers in the Immediate Postpartum Period

    … in the review revealed that CYP2D6, OPRM1 A118G, UGT2B7 C802T and ABCB1 G2677AT may contribute to postpartum analgesia or adverse events. A nested cohort study was performed to explore the role of codeine pharmacogenetics in a population of 98 post-cesarean women. Participants were genotyped and …

    toronto-retro Repository record for Therapeutic and Substance Abuse Biomarkers in the Immediate Postpartum Period (opens in a new tab)

  4. Pharmacokinetics, limited sampling strategies, and pharmacogenetics of mycophenolic acid in thoracic transplant recipients

    … respectively. For both transplant groups, UGT2B7 variants 802T (*2a) and -138A (*2g) were associated with increased AcMPAG AUC (~3-fold) and AcMPAG/MPA (~10-fold) in multivariate analyses, respectively, and high AcMPAG exposure and metabolic ratio were associated with poor clinical …

    ubc Repository record for Pharmacokinetics, limited sampling strategies, and pharmacogenetics of mycophenolic acid in thoracic transplant recipients (opens in a new tab) Download PDF for Pharmacokinetics, limited sampling strategies, and pharmacogenetics of mycophenolic acid in thoracic transplant recipients (opens in a new tab)

  5. Multidimensional Methods: Applications in Drug-Enzyme Intrinsic Clearance Determination and Comprehensive Two-Dimensional Liquid Chromatography Peak Volume Determination

    … of dextrorphan (DR) as metabolized by the UGT2B7 enzyme to obtain dextrorphan glucuronide (DR-G). A direct injection liquid chromatography-mass spectrometry (LC-MS) method was used to monitor products using the pseudo-first-order (PFO) model. Standard enzymatic incubations were also …

    vcu Repository record for Multidimensional Methods: Applications in Drug-Enzyme Intrinsic Clearance Determination and Comprehensive Two-Dimensional Liquid Chromatography Peak Volume Determination (opens in a new tab)

  6. Roles of biotransformation in the antitumour activity and toxicology of the hypoxia-activated pre-prodrug PR-104

    … followed by human then rodent microsomes. UGT2B7 appeared to be the only human isoform able to conjugate PR-104A, which was further confirmed by a strong correlation between UGT2B7 protein content and glucuronidation activity in microsomes from different individuals. The results suggest …

    auckland-ms Repository record for Roles of biotransformation in the antitumour activity and toxicology of the hypoxia-activated pre-prodrug PR-104 (opens in a new tab)

  7. Pharmacogenetics of Tamoxifen in Asian Breast Cancer Patients

    … II conjugating enzymes identified UGT1A4 but not UGT2B7, UGT2B15 and SULT1A1 to be a determinant tamoxifen disposition. UGT1A4*3 (142T>G, rs2011425) and the associated haplotype were associated with higher tamoxifen-N-glucuronide concentrations and MRTAM-N-GLUC/TAM. Thus, CYP2D6 and UGT1A4 …

    nus Repository record for Pharmacogenetics of Tamoxifen in Asian Breast Cancer Patients (opens in a new tab) Download file for Pharmacogenetics of Tamoxifen in Asian Breast Cancer Patients (opens in a new tab)

  8. Opioide zur lokalen Ausschaltung schwerster Schmerzen bei Verletzung der Haut

    … der UDP-Glucuronosyltransferase 2B7 (UGT2B7), dem wichtigsten Enzym des Morphinstoffwechsels, in primären humanen Keratinozyten und Fibroblasten sowie der Keratinozytenzelllinie HaCaT bestimmt. Es konnte gezeigt werden, dass UGT2B7 in den drei Zelltypen nicht bzw. nur in Spuren …

    fu-berlin Repository record for Opioide zur lokalen Ausschaltung schwerster Schmerzen bei Verletzung der Haut (opens in a new tab)

  9. Study of Genetic Factors Involved in Pain Perception and Morphine Analgesia in Cancer-related Pain

    … enzyme UDP-Glucuronosyltransferase 2B7 (UGT2B7); transporters ATP binding cassette sub-family B member 1 transporter (ABCB1); and organic anion-transporting polypeptides 1A2 (OATP1A2), along with pain and inflammation modulators, such as catechol-O-methyltransferase (COMT) and several …

    kent Download PDF for Study of Genetic Factors Involved in Pain Perception and Morphine Analgesia in Cancer-related Pain (opens in a new tab)

  10. Sinalização androgênica em tumores de próstata

    … INFG, SHBG, STS, SPAG11B, TGM4, UGT1A8, UGT2A1 e UGT2B7) não apresentaram expressão em nenhum dos grupos e 7 genes (ESR1, IL6, NCOA2, NCOA4, PDS5B, SRD5A1 e SRD5A2) apresentaram expressão em ambos os grupos, mas não foi possível analisá-los. Na expressão proteica do AR encontramos que este está …

    brazil-ufrgs Repository record for Sinalização androgênica em tumores de próstata (opens in a new tab)

  11. Characterization of Interindividual Variability and Differential Tissue Abundance of UGT2B17: Discovery of a Potential Biomarker and Drug Interaction Prediction

    … 1 (CES1), CES2, UGT1A1, UGT1A3, UGT1A10, UGT2B7, UGT2B17, sulfotransferase 1A1 (SULT1A1), SULT1A3, SULT1B1, and SULT2A1. We also found good enzyme abundance-activity correlations, demonstrating that CHIMs are functionally active with respect to xenobiotic metabolism. This dissertation …

    washington Repository record for Characterization of Interindividual Variability and Differential Tissue Abundance of UGT2B17: Discovery of a Potential Biomarker and Drug Interaction Prediction (opens in a new tab)

  12. Prediction of Drug-Induced Cholestasis Caused by Transporter and/or Enzyme Inhibition-Derived Cell Stress

    … acid N-acetyltransferase (BAAT), UGT1A3, UGT2B7, SULT2A1, and CYP3A4) for 47 marketed drugs with various degrees of DILI was generated. Concurrently, considering human exposure information, a comprehensive statistical analysis was performed to improve our overall understanding of the …

    zurich

  13. Influence of genetic variability on the clinical pharmacology of carbamazepine and lamotrigine

    … g.5734C>A, EPHX1 c.337T>C, EPHX1 c.416A>G, UGT2B7 c.802C>T, ABCB1 c.1236C>T, ABCB1 c.2677G>T/A, ABCB1 c.3435C>T and SCN2A c.56G>A. The prevalence of these common polymorphisms was evaluated in a 400-strong study population from a single research unit. Minor allele frequency ranged between …

    glasgow Download PDF for Influence of genetic variability on the clinical pharmacology of carbamazepine and lamotrigine (opens in a new tab)

  14. IN SILICO APPROACHES IN DRUG DESIGN AND DEVELOPMENT: APPLICATIONS TO RATIONAL LIGAND DESIGN AND METABOLISM PREDICTION

    … three-dimensional structure of the enzyme UGT2B7, the main isoform of glucuronidation enzymes in humans, in complex with the cofactor UDPGA and a typical substrate, such as Naproxen. The paths of the substrate entering to the binding site and the egress of the product have been investigated …

    milano Repository record for IN SILICO APPROACHES IN DRUG DESIGN AND DEVELOPMENT: APPLICATIONS TO RATIONAL LIGAND DESIGN AND METABOLISM PREDICTION (opens in a new tab)

  15. Quantification and Prediction of Human Fetal (-)-Δ9-tetrahydrocannabinol (THC)/11-OH-THC Exposure to Inform Neurodevelopmental Toxicity of Cannabis

    … was significantly metabolized by CYP3A (51%) and UGT2B7 (25%). In the fetal liver, both compounds were nearly completely metabolized by CYP3A7. The presence of intestinal and fetal liver metabolism, respectively, will impact bioavailability after oral THC administration and fetal exposure, …

    washington Repository record for Quantification and Prediction of Human Fetal (-)-Δ9-tetrahydrocannabinol (THC)/11-OH-THC Exposure to Inform Neurodevelopmental Toxicity of Cannabis (opens in a new tab)

  16. Pediatric Physiologically Based Pharmacokinetic (PBPK) Modeling to Advance Knowledge of Breastfeeding Infant Exposure to Maternal Medications

    … were ascertained as UGT1A7 4%, UGT1A9 16%, UGT2B7 10%, CYP3A4 38%, CYP2C19 21%, and CYP2C9 11%. This information was used to populate the CBD pediatric PBPK model. Results from the linear regression analysis with maternal factors, including administration type, dose-frequency of use, and …

    waterloo Repository record for Pediatric Physiologically Based Pharmacokinetic (PBPK) Modeling to Advance Knowledge of Breastfeeding Infant Exposure to Maternal Medications (opens in a new tab)